Clinical trials
Observational Sickle Cell Trait trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2020 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Recruiting | 4 |
| Active, not recruiting | 1 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Heart, Lung, and Blood Institute (NHLBI) | 2 |
| UConn Health | 2 |
| Albert Einstein College of Medicine | 1 |
| Medical University of South Carolina | 1 |
| National Alliance for Sickle Cell Centers | 1 |
| National Human Genome Research Institute (NHGRI) | 1 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1 |
| Pfizer | 1 |
| Sanguine Biosciences | 1 |
| University of South Florida | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sickle Cell Trait | 13 |
| Anemia, Sickle Cell | 9 |
| Diabetes Mellitus | 2 |
| Renal Insufficiency, Chronic | 2 |
| Acquired Immunodeficiency Syndrome | 1 |
| Alopecia Areata | 1 |
| Arthritis, Psoriatic | 1 |
| Asthma | 1 |
| Bipolar Disorder | 1 |
| Breast Neoplasms | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.